New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
Pfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September. Source
Read MorePfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September. Source
Read MoreInvestors are wrapping up what's set to be a third straight winning week for the S&P 500 and the Dow
Read MoreThe HHS program aims to maintain broad access to Covid shots and treatments after the federal government shifts those products
Read MoreNvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners,
Read MoreModerna said the submission is based on the FDA's recommendation that vaccine makers update their jabs to target omicron subvariant
Read MoreThe FDA's strain selection puts Pfizer, Moderna and Novavax on track to deliver updated coronavirus shots in time for the
Read MoreCash-strapped Covid vaccine Novavax still faces a nunber of challenges, chiefly competing with Pfizer and Moderna in the U.S. commercial
Read MoreThe Biden administration and drugmakers Pfizer and Moderna have announced programs that aim to help uninsured Americans access Covid shots
Read MoreThe FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that
Read More